期刊文献+

盐酸羟考酮控释片治疗晚期癌症疼痛的临床应用 被引量:3

暂未订购
导出
摘要 疼痛是晚期癌症患者的常见症状,其发生率高达60~90%。每年全球约有900万人遭受癌痛困扰,到2021年此数值将升至1500万,癌痛全面影响患者的生存质量,镇痛治疗意义深远[1]。盐酸羟考酮控释片(商品名:奥施康定)是一种新型强阿片类镇痛剂。其主要特点是有即释和控释两种释放方式。起效迅速。
出处 《福州总医院学报》 2010年第4期247-248,共2页 Journal of Fuzhou General Hospital
  • 相关文献

参考文献8

  • 1李小梅,刘端祺,李红英,王艳梅.恶性肿瘤患者临终前的阿片类药物止痛回顾[J].中国肿瘤临床,2005,32(23):1358-1360. 被引量:36
  • 2Kapil R, Nolting A, Roy P, et al. Pharrnaeokinede properties of combination oxycodone plus raeelltilie ibuprofen; two randomized, open- label, crossover studies in healthy adult volunteers . Clin Ther, 2004, 26 (12): 2015-2025.
  • 3于世英,邱红,马振山,陈嘉,张英,陈立正,王东林,马智勇.盐酸吗啡缓释片治疗癌症疼痛的临床疗效分析[J].中华医学杂志,2004,84(6):450-455. 被引量:33
  • 4刘华,王蔚,郑垂志,邢雪花.癌症三阶梯止痛563例分析[J].中国肿瘤临床,2004,31(23):1346-1348. 被引量:79
  • 5Arcuri E, Ginobbi P, TireUi W, et al. Preliminary in vivo experi- mental evidence on intranmmoral moohine uptake. Possible cliniea / impficafions in cancer pain and opioid pesponsiveness. J Pain Symp- tom Manage, 2002, 24 (1): 1-3.
  • 6Clohisy DR, Mantyh PW. Bone cancer paill. Cancer, 2003, 79 (3 Suppl) : 866 - 783.
  • 7Smith MT, Ross FB, Nielsen CK, et al. Oxyeodone has a distincdy diferent pharmacology from morphohine. Eurj Pain. 2001, 5 (suppI, A): 135-136.
  • 8Hermos JA, Young MM, Gag-non DR, et al. Characterizations of long - term oxycodone / acetaminophen presczil; dons in veteran patients. Arch Intern Med, 2004, 164 (22): 2361-2366.

二级参考文献21

  • 1Yu SY. Sustained release morphine for cancer pain management. J Clinic Oncology, 1998,3:44-45.于世英.吗啡控释片治疗癌痛的临床研究.临床肿瘤学杂志1998,3:44-45.
  • 2Sun Y. Assesment the quality of life for cancer patients in China. In: SunY, Gu WP, eds Guideline for cancer pain relief by three steps. 2nd ed. Beijing: Beijing Medical University PublishingHouse, 2002. 100-101.孙燕.我国试行的肿瘤病人生活质量评分.见:孙燕
  • 3WHO. Medical nedd for opioid analgesics. In: WHO, ed. Achieving balance in national opioids control policy: guidelines for assessment. Geneva: WHO, 2000, 3-4.
  • 4Joranson DE, Ryan KM, Gilson AM, et al. Trends in medical useand abuse of opioid analgesics. JAMA, 2000, 283:1710-1714.
  • 5Klepstad P, Kaasa S, Jystad A, et al. Immediate- or sustainedrelease morphine for dose finding during start of morphine to cancer patients: a randomized, double-blind trial. Pain, 2003, 101:193-98.
  • 6Warfield CA. Controlled-release morphine tablets in patients with chronic cancer pain. A narrative review of controlled clinical trials. Cancer, 1998, 82:2299-2306.
  • 7Chemy NI. The management of cancer pain. CA Cancer J Clin, 2000, 50: 70-116.
  • 8Tassain V, Attal N, Fletcher D, et al. Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain, 2003, 104:389-400.
  • 9Yu SY, Wang XS, Chen Y, et al. Special aspects of cancer pain management in a Chinese general hospital. Eur J Pain, 2001,5:15-20.
  • 10Wang XS, Li TD, Yu SY, et al. China: Status of pain and palliativecare. J Pain and Sympt Manage, 2002, 24: 177-179.

共引文献133

同被引文献23

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部